Skip To Main Content
Hiba Kazmi on Muck Rack

Hiba Kazmi

As seen in: Labcorp Drug Development Blog

Get in touch with Hiba

Contact Hiba, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Articles

5 key takeaways from a Labcorp webinar: Current and emerging Parkinson’s disease biomarkers to advance clinical research

|
By Robert Martone, Neurology Biomarkers, Hiba Kazmi, Biomarker Scientist
| Labcorp Drug Development Blog
Insights from our three guest speakers: Robert Martone, Associate Director, Neurology Biomarkers, Labcorp Biomarker Solution Center, Labcorp Drug Development Hiba Kazmi, PhD, Biomarker Scientist, IXICO Antoniya Todorova, MD, PhD, Medical Director, Labcorp Drug Development On September 12, three leading biomarker specialists shared their insights on ongoing research in Parkinson’s disease (PD) biomarkers to enable earlier detection of neurodegeneration, monitor disease progression, elucidate...
Open in Who Shared Issue with article?

Late onset depression: dopaminergic deficit and clinical features of prodromal Parkinson’s disease: a cross-sectional study

|
By Hiba Kazmi, Zuzana Walker, Jan Booij, Faraan Khan
| bmj.com
Late onset depression: dopaminergic deficit and clinical features of prodromal Parkinson’s disease: a cross-sectional study http://orcid.org/0000-0003-2962-598XHiba Kazmi1, Zuzana Walker2,3, Jan Booij4, Faraan Khan5, Sachit Shah6, Carole H Sudre7,8, Joshua E.J. Buckman9,10, http://orcid.org/0000-0002-9872-6680Anette-Eleonore Schrag1 1Department of Clinical and Movement Neuroscience, UCL Institute of Neurology, London, UK 2Division of Psychiatry, University College London, London, UK 3St...
Open in Who Shared Issue with article?
See all 2 articles